Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL89183 | 1.00 | ALDH1A1 (0.54) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL13412441 | 1.00 | ALDH1A1 (0.54) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL11312759 | 0.93 | CYP1A2 (0.50) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL7875391 | 0.88 | ALDH1A1 (0.51) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL10915882 | 0.88 | ALDH1A1 (0.51) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL8488475 | 0.87 | ALDH1A1 (0.45) | ALDH1A1ALOX15TDP1USP2DGKA | |
| SCHEMBL10472514 | 0.86 | ALDH1A1 (0.49) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL11323271 | 0.85 | ALDH1A1 (0.44) | ALDH1A1ALOX15TDP1USP2CYP1A2 | |
| SCHEMBL3648153 | 0.84 | MGLL (0.55) | MGLL | |
| SCHEMBL11779501 | 0.84 | DGKA (0.44) | ALDH1A1DGKAEPHX2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129552-B2 | for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-03-06 | — | — | US | disclosed |
| US-8129552-B2 | for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20080214849-A1 | PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) | 2008-09-04 | — | — | US | disclosed |
| US-20080214849-A1 | PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) | 2008-09-04 | — | — | US | disclosed |
| EP-1102775-B1 | NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | MAX PLANCK GESELLSCHAFT (DE) | 2005-06-08 | — | — | EP | disclosed |
| EP-1102775-A1 | NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008031-A1 | NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2000-02-17 | — | — | WO | disclosed |
| EP-0194144-B1 | PROCESS FOR THE PREPARATION OF 2-ALKYL-CYCLOPENT-2-ENONES | Montedison S.p.A. (IT) | 1991-09-11 | — | — | EP | disclosed |
| US-4673759-A | Process for the preparation of 2-alkyl cyclopent-2-enones | MONTEDISON S.P.A. (IT) | 1987-06-16 | — | — | US | disclosed |
| EP-0194144-A2 | Process for the preparation of 2-Alkyl-Cyclopent-2-Enones | Montedison S.p.A. (IT) | 1986-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214849-A1 | PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | PHOSPHO1, PLTP, SGMS1 | ALDH1A1 4394/4885ALOX15 110/4885TDP1 2874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.